033780 - KT&G Corporation

033780 Summary
Consumer
Stock Price & Overview
₩172,500 -2,200 (-1.26%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩172,500  ≈ US$123  ·  Market cap ₩17.9tn (≈ $12.8bn)

KT&G's Profit Recovery Is Coming From Costs, Not From Price

Summary

  • KT&G posted a fourth consecutive quarter of double-digit operating profit growth, with second-quarter operating income of ₩414.5bn on revenue of ₩1,701.6bn.
  • First-half operating margin rose about two points to 22.9%, and selling and administrative expense fell almost exactly the same two points as a share of revenue.
  • Gross margin was 49.5% in the first half against 49.6% a year earlier, so none of the improvement came from pricing or mix.
  • Management raised full-year guidance, taking revenue growth to 5-7% from 3-5% and operating profit growth to 10-13% from 6-8%.
  • I'd want gross margin to move before treating this as a structural turn, and the second-half leaf cost line is where that would appear.

KT&G Corporation (KRX:033780) reported second-quarter revenue of ₩1,701.6bn and operating income of ₩414.5bn, up 9.9% and 18.5% respectively. That was the fourth consecutive quarter in which operating profit grew at a double-digit rate, and it was enough for management to raise full-year guidance twice over: revenue growth from a range of 3-5% to 5-7%, and operating profit growth from 6-8% to 10-13%.

Profit growing at roughly twice the rate of sales, for a year, at a mature tobacco company. That deserves an explanation, and the income statement gives a specific one.

The Improvement Is Entirely Below The Gross Line

Take the first half of 2026 against the first half of 2025.

Revenue: ₩3,405.2bn against ₩3,039.0bn, up 12.0%. Gross profit: ₩1,684.6bn against ₩1,506.1bn. As a percentage, gross margin was 49.5% this year and 49.6% last year. Flat to the first decimal.

Selling, general and administrative expense: ₩905.6bn against ₩870.6bn. In absolute terms it went up. As a share of revenue it went from 28.7% to 26.6%, a fall of two percentage points.

Operating margin over the same two halves went from 20.9% to 22.9% — up two percentage points. The two numbers match almost exactly, and that is not a coincidence. Every point of KT&G's operating margin improvement this year came from spreading fixed overhead across a larger revenue base and holding costs down. None came from selling at better prices or shifting toward higher-margin products.

That is a real achievement and a limited one. Overhead leverage is finite. A company can improve its expense ratio from 28.7% to 26.6%; it cannot repeat that trick indefinitely, and the base gets harder each year.

The Ten Points That Went Missing

Zoom out and the picture is less flattering than four quarters of double-digit growth suggests.

Cost of revenue as a share of sales: 42.1% in FY2020, 49.4% in FY2022, 52.1% in FY2023, 52.2% in FY2025. Gross margin accordingly fell from 57.9% in FY2020 to 47.8% in FY2025 — ten percentage points in five years.

Operating income tells the same story in cash. It was ₩1,473.2bn in FY2020. It was ₩1,343.7bn in FY2025. Six years on, after a recovery from the ₩1,167.3bn trough of FY2023, KT&G still earns less from operations than it did before the pandemic, on revenue that grew 30% over the same span.

Operating margin went from 29.1% in FY2020 to 20.4% in FY2025. The second quarter of 2026 recovered to 24.4%, which is genuine progress and still five points short.

Where did ten points of gross margin go? The filings do not break it out, but two things are visible. Leaf tobacco input costs rose sharply through the inflation of 2021-23 and have not fully reversed. And the mix shifted toward supply arrangements and overseas volume that carry lower gross margins than a domestic cigarette sold into KT&G's own distribution.

Inventory explains why this takes so long to fix. KT&G carried ₩3,100.1bn of inventories at the end of June against annual cost of revenue of ₩3,435.3bn — nearly eleven months of cost. Tobacco leaf is aged deliberately, which means expensive leaf bought two years ago is still flowing through cost of goods today. When input costs fall, the margin benefit arrives with a long lag. That works in both directions and it is the single best reason to be patient with the gross margin line.

What Is Actually Growing

Management attributes the improvement to two things: a significant increase in operating profit from the global business, and momentum in the domestic next-generation product business, meaning heated tobacco.

The summary financial statements do not carry segment detail, so I cannot verify the split or size either contribution. What can be said is that the composition matters more than usual here. KT&G manufactures the heated tobacco sticks that Philip Morris International sells outside Korea under a long-running supply agreement, so part of its overseas growth is effectively a manufacturing contract with a competitor rather than a branded position of its own. That is good business with a lower margin and less pricing power than selling its own brand.

If the global profit growth is coming from that supply relationship, it explains both the revenue growth and the absence of gross margin improvement. If it is coming from KT&G's own overseas cigarette brands, the margin should eventually follow. Which of those is happening is the segment disclosure worth reading.

Working capital is the one line that has moved faster than it should. Trade receivables went from ₩1,691.4bn at the end of December to ₩2,048.8bn at the end of June, up 21% against revenue growth of 12%. One half is not a trend, but growth concentrated in export and supply channels typically comes with longer payment terms, and that is what this looks like.

The Case That Cost Discipline Is Enough

The counter-argument is straightforward and probably right for a tobacco investor. Nobody buys KT&G expecting revenue growth or margin expansion. They buy it for cash generation and distributions, and on that measure the company is delivering more than it has in years: a 9.5% share cancellation in April, a quarterly dividend raised 43% to ₩2,000, and a new medium- to long-term return policy promised for the fourth quarter.

Working back from the 1.1% stated yield on the August dividend, the shares sat near ₩182,000 in early August, implying a market value around ₩18.9tn against trailing four-quarter net income of about ₩1,441.2bn. Roughly thirteen times earnings, with the annualized dividend worth about 4.4% before any buyback. For a business whose profit is growing at 10-13% on raised guidance, that is not an expensive number, and the margin history matters less than the cash does.

There is also a fair point that FY2020 is the wrong comparison. Tobacco volumes spiked during the pandemic across most markets, and margins in that year flattered every producer. Comparing to 2020 sets a bar that was itself unusual.

What Would Settle It

Gross margin in the second half. It was 50.7% in the second quarter, its best in the eight quarters on file, and 48.3% in the first. If the third and fourth quarters both come in above 50%, the leaf cost cycle has turned and the recovery is structural rather than administrative. Two more quarters near 48% would mean the input problem is still working through inventory and the profit growth remains entirely a cost-control story with a ceiling.

Second, the segment split between domestic, global and next-generation products in the third-quarter disclosure — specifically whether the global profit growth carries a margin comparable to the domestic business or well below it.

Third, receivables. Twenty-one percent growth against 12% revenue growth is worth one more quarter of attention before it becomes a question.

Written with AI assistance from Korean-language sources and checked against the filing or article it rests on. kstock does not issue buy, sell or hold ratings and this is not investment advice.

One Korean filing a day, in English.

kstock reads DART every morning and writes up what moved — the contract, the buyback, the number that does not add up. The daily post and a Saturday roundup, by email.

Free. Unsubscribe anytime. Sent by Substack · Privacy